Endothelin-1-induced arachidonic acid release by cytosolic phospholipase A2 activation in rat vascular smooth muscle via extracellular signal-regulated kinases pathway

Biochem Pharmacol. 2002 Aug 1;64(3):425-31. doi: 10.1016/s0006-2952(02)01066-3.

Abstract

The present study investigates whether endothelin-1 (ET-1), like noradrenaline (NA), stimulates the release of arachidonic acid (AA) via cytosolic phospholipase A2 (cPLA2) in rat tail artery. In tail artery segments labelled with [3H]AA, ET-1-induced AA release in a concentration-dependent manner with an EC50 of 1.3 nM. The effect of ET-1 was inhibited by bosentan and was insensitive to BQ788, suggesting the involvement of ETA receptor. The stimulation of AA release induced by ET-1 was prevented by arachydonyl trifluoromethyl ketone (AACOCF3), a selective inhibitor of cPLA2 and not by RHC80267, a diacylglycerol lipase inhibitor. Furthermore, PD98059, inhibitor of mitogen-activated protein kinase kinase (MEK) cascade and calphostin C, a protein kinase C (PKC) inhibitor, prevented the stimulation of AA release induced by ET-1 and NA. Immunoblotting of the cytosolic fraction of rat tail arteries stimulated with ET-1 or NA showed an increase in extracellular signal-regulated kinases (ERKs) phosphorylation and this effect was abolished by calphostin C treatment. These findings show that in rat tail artery ET-1 and NA induce a sequential activation of protein kinase C and extracellular signal-regulated kinases that results in stimulation of AA release via cPLA2 activation. This may represent a general pathway by which G-proteins coupled receptors stimulate AA release and its metabolites in vascular smooth muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism*
  • Arachidonic Acids / pharmacology
  • Arteries
  • Carrier Proteins / pharmacology
  • Cyclohexanones / pharmacology
  • Drug Interactions
  • Endothelin Receptor Antagonists
  • Endothelin-1 / pharmacology*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Intracellular Signaling Peptides and Proteins*
  • Male
  • Mitogen-Activated Protein Kinases / metabolism*
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / metabolism
  • Norepinephrine / pharmacology
  • Phospholipases A / metabolism*
  • Phospholipases A2
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Tail
  • Tritium

Substances

  • Arachidonic Acids
  • Carrier Proteins
  • Cyclohexanones
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • protein kinase modulator
  • arachidonyltrifluoromethane
  • Tritium
  • Arachidonic Acid
  • 1,6-bis(cyclohexyloximinocarbonyl)hexane
  • Mitogen-Activated Protein Kinases
  • Phospholipases A
  • Phospholipases A2
  • Norepinephrine